BOCCHIA MONICA

Contacts

Teaching activities

Completion accademic year: 2026/2027

Course year: 2 First cycle degree (DM 270) DIETISTIC A.Y. 2025/2026
Course year: 4 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2023/2024
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2024/2025
Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2025/2026
Course year: 4 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2023/2024

Completion accademic year: 2025/2026

Course year: 2 First cycle degree (DM 270) DIETISTIC A.Y. 2024/2025
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2023/2024
Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2024/2025
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023

Research

Ultime pubblicazioni:

  • Gavioli, F., Caggiano, V., Sbalchiero, J., Frassi, M., Crisafulli, F., Cavazzana, I., et al. (2026). VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries. SEMINARS IN ARTHRITIS AND RHEUMATISM, 77 [10.1016/j.semarthrit.2026.152932]. - view more
  • Caggiano, V., Sbalchiero, J., Frassi, M., Martin-Nares, E., Hinojosa-Azaola, A., Sikora, M., et al. (2026). Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1659758]. - view more
  • D'Amato, M., Rapolla, C.M., Benedetti, E., Bocchia, M., Capochiani, E., Carlomagno, G., et al. (2026). Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. CLINICAL AND EXPERIMENTAL MEDICINE, 26(1) [10.1007/s10238-026-02100-y]. - view more
  • Del Prete, R., Tusha, V., Simon-Molas, H., Gazziero, V.A., Nardi, F., Drago, R., et al. (2026). IL21—STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemia. HEMASPHERE, 10(1) [10.1002/hem3.70292]. - view more
  • Palandri, F., Caocci, G., Abruzzese, E., Tiribelli, M., Morsia, E., Farina, M., et al. (2026). Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis. CANCER, 132(4) [10.1002/cncr.70320]. - view more